Related Experiment Video
Updated: Aug 17, 2026
Initial Evaluation of Antibody-conjugates Modified with Viral-derived Peptides for Increasing Cellular Accumulation and Improving Tumor Targeting
Published on: March 8, 2018
92nd AACR. Anti-angiogenic agents
1Vrije Universiteit Medical Centre, Department of Medical Oncology, De Boelelaan 1117, NL-1081 HV, Amsterdam, The Netherlands. e.boven@azvu.nl
Abstract:
This year's meeting covered a vast number of subjects of which a few warrant specific discussion due to current interest. Research activities are expanding in the potential use of anti-angiogenic and antivascular targeting agents for treatment of cancer. Studies on the mechanisms of action of this wide variety of agents remain the focus of attention. A large series of abstracts was dedicated to apoptosis and approaches to stimulate tumor cells to enter the apoptotic death pathway. Insight into DNA damage and repair is increasing, as well as measures to circumvent cellular drug resistance. Another subject to mention is the generation of dendritic cells for immunotherapy. And last, but not least, presentations concerning the state-of-the-art of microarray technology not only included encouraging data, but also reviewed the problems encountered when using patient's tumor samples for analysis.
Insights
This research explores novel cancer treatments, focusing on anti-angiogenic and antivascular agents, apoptosis, DNA repair, and immunotherapy. Advances in microarray technology for tumor analysis are also discussed.
Area of Science:
- Oncology
- Immunology
- Molecular Biology
Background:
- Expanding research in anti-angiogenic and antivascular agents for cancer treatment.
- Focus on understanding the mechanisms of action for various cancer-targeting agents.
- Growing interest in apoptosis induction for cancer therapy.
Purpose of the Study:
- To discuss current research interests in cancer treatment modalities.
- To highlight advancements in understanding cancer cell mechanisms and resistance.
- To review the application and challenges of microarray technology in cancer research.
Main Methods:
- Review of abstracts presented at a scientific meeting.
- Discussion of research on apoptosis and DNA damage/repair mechanisms.
- Exploration of dendritic cell generation for immunotherapy.
Main Results:
- Significant focus on anti-angiogenic and antivascular targeting agents.
- Advancements in understanding apoptosis induction and DNA repair pathways.
- Encouraging data and identified challenges in microarray technology for patient tumor samples.
Conclusions:
- Current cancer research is exploring diverse therapeutic strategies including targeted agents and immunotherapy.
- Understanding cellular mechanisms like apoptosis and drug resistance is crucial.
- Microarray technology shows promise but requires further refinement for clinical application.
